Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Bayer AG PK (BAYRY)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
13.29 -0.19    -1.41%
17/09 - Closed. Currency in USD ( Disclaimer )
After Hours
13.30
-0.00
-0.00%
20:59:47 - Delayed Data
  • Volume: 550,853
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 13.21 - 13.39
Type:  Equity
Market:  United States
ISIN:  US0727303028 
S/N:  072730302
Bayer AG PK 13.29 -0.19 -1.41%
IndustryMajor Drugs
SectorHealthcare
Employees

99439

Equity Type

ADR

Bayer AG is a German-based life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The company is focusing on their oncology platform o Targeted Alpha Therapies for treating prostate cancer. Th Consumer Health segment develops, produces and markets nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others. The Crop Science segment researches, develops and markets crop protection solutions and seeds, and includes the subsidiary Monsanto. The Animal Health segment is engaged in the development, production and marketing of prescription and non

Contact Information

Phone +49-214-301
Fax 214-3066328

Top Executives

Name Age Since Title
Paul M. L. Achleitner 65 2002 Member of Supervisory Board
Horst Baier 65 2020 Independent Member of Supervisory Board
Petra Reinbold-Knape 62 2012 Member of Supervisory Board
André van Broich 51 2012 Member of Supervisory Board
Michael Schmidt-Kießling 62 2012 Member of Supervisory Board
Simone Bagel-Trah 52 2014 Independent Member of Supervisory Board
Norbert Winkeljohann 64 2018 Independent Chairman of Supervisory Board
Daniel Hartert 63 - Chairman of Executive Board - Bayer Business Services
Andrea Sacher 40 2020 Member of Supervisory Board
Frank Löllgen 60 2015 Member of Supervisory Board
Heike Hausfeld 56 2017 Member of Supervisory Board
Reiner Hoffmann 66 2006 Member of Supervisory Board
Robert Gundlach 64 2019 Member of Supervisory Board
Ertharin Cousin 64 2019 Independent Member of the Supervisory Board
Colleen A. Goggins 67 2017 Independent Member of Supervisory Board
Alberto Weisser 66 2021 Independent Supervisory Board Member
Otmar D. Wiestler 65 2014 Independent Member of Supervisory Board
Norbert W. Bischofberger 65 2017 Independent Member of Supervisory Board
Thomas Elsner 63 2017 Member of Supervisory Board
Günter Hilken 67 - Chairman of Executive Board - Currenta
Fei-Fei Li 45 2021 Independent Member of the Supervisory Board
Oliver Zuhlke 53 2007 Vice Chairman of Supervisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BAYRY Comments

Write your thoughts about Bayer AG PK
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Fabio Ravanelli
Fabio Ravanelli Oct 28, 2020 20:12
Saved. See Saved Items.
This comment has already been saved in your Saved Items
best price to open a new position?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email